Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    April 2017
  1. DAY GS, Gordon BA, Jackson K, Christensen JJ, et al
    Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2017 Apr 7. doi: 10.1097/WAD.0000000000000196.
    PubMed     Text format     Abstract available


    March 2017
  2. MORENO DJ, Pino S, Rios A, Lopera F, et al
    Genetic Ancestry and Susceptibility to Late-Onset Alzheimer's Disease (LOAD) in the Admixed Colombian Population.
    Alzheimer Dis Assoc Disord. 2017 Mar 31. doi: 10.1097/WAD.0000000000000195.
    PubMed     Text format     Abstract available


  3. OPOKU ST, Apenteng BA, Lin G
    Temporal Trends and Rural-Urban Differences in Hospital Length of Stay for Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2017 Mar 14. doi: 10.1097/WAD.0000000000000183.
    PubMed     Text format     Abstract available


    January 2017
  4. VELAYOS-BAEZA A, Danek A
    Chorein Deficiency and Alzheimer Disease: An Intriguing, Yet Premature Speculation.
    Alzheimer Dis Assoc Disord. 2017 Jan 24. doi: 10.1097/WAD.0000000000000186.
    PubMed     Text format    


  5. LAZARCZYK MJ, Haller S, Savioz A, Gimelli S, et al
    Heterozygous Deletion of Chorein Exons 70-73 and GNA14 Exons 3-7 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jan 10. doi: 10.1097/WAD.0000000000000185.
    PubMed     Text format    


    December 2016
  6. PARK SA, Chae WS, Kim HJ, Shin HS, et al
    Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea.
    Alzheimer Dis Assoc Disord. 2016 Dec 23. doi: 10.1097/WAD.0000000000000184.
    PubMed     Text format     Abstract available


  7. RITTER AR, Leger GC, Miller JB, Banks SJ, et al
    Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Alzheimer Dis Assoc Disord. 2016 Dec 21. doi: 10.1097/WAD.0000000000000181.
    PubMed     Text format     Abstract available


    November 2016
  8. TREBBASTONI A, Marcelli M, Mallone F, D'Antonio F, et al
    Attenuation of Choroidal Thickness in Patients With Alzheimer Disease: Evidence From an Italian Prospective Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  9. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Sarcopenia is Associated With Impairment of Activities of Daily Living in Japanese Patients With Early-Stage Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  10. MONSELL SE, Mock C, Fardo DW, Bertelsen S, et al
    Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  11. DEVANAND DP, Pelton GH, D'Antonio K, Strickler JG, et al
    Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  12. VERHULSDONK S, Lange-Asschenfeldt C, Hoft B, Schwender H, et al
    Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  13. DE LUCIA N, Grossi D, Trojano L
    Closing-in is Related to Daily Living Functioning in Patients With Mild-to-Moderate Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


    October 2016
  14. PRUZIN JJ, Schneider JA, Capuano AW, Leurgans SE, et al
    Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  15. ZUCCHELLA C, Bartolo M, Bernini S, Picascia M, et al
    Modeling Alzheimer's Disease Through Functional Independence and Participation.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    September 2016
  16. LAGARDE J, Sarazin M, Chauvire V, Stankoff B, et al
    Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    July 2016
  17. CANEVELLI M, Kelaiditi E, Del Campo N, Bruno G, et al
    Predicting the Rate of Cognitive Decline in Alzheimer Disease: Data From the ICTUS Study.
    Alzheimer Dis Assoc Disord. 2016;30:237-42.
    PubMed     Text format     Abstract available


    June 2016
  18. GALETTA KM, Chapman KR, Essis MD, Alosco ML, et al
    Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    May 2016
  19. KIM MJ, Seo SW, Kim ST, Lee JM, et al
    Diffusion Tensor Changes According to Age at Onset and Apolipoprotein E Genotype in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  20. TARRANT SD, Bardach SH, Bates K, Nichols H, et al
    The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  21. CURTO M, Martocchia A, Ferracuti S, Comite F, et al
    Increased Total Urinary Cortisol (tUC) and Serum Brain-derived Neurotrophic Factor (BDNF) Ratio in Alzheimer Disease (AD)-affected Patients.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  22. CHANG TS, Teng E, Elashoff D, Grill JD, et al
    Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    March 2016
  23. ORTEGA-ROJAS J, Morales L, Guerrero E, Arboleda-Bustos CE, et al
    Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    February 2016
  24. SEVIGNY J, Suhy J, Chiao P, Chen T, et al
    Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  25. LEE ES, Yoo K, Lee YB, Chung J, et al
    Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  26. D'ANTONIO F, Imbriano L, Campanelli A, de Lena C, et al
    Progressive Language Impairment in an English-Italian Bilingual Woman With Alzheimer Disease: An 18-Month Follow-up.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


    January 2016
  27. LAZARCZYK MJ, Haller S, Gimelli S, Bena F, et al
    Heterozygous Chorein Deficiency in Probable Tau-negative Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  28. GORUCU YILMAZ S, Erdal ME, Avci Ozge A, Sungur MA, et al
    SNP Variation in MicroRNA Biogenesis Pathway Genes as a New Innovation Strategy for Alzheimer Disease Diagnostics: A Study of 10 Candidate Genes in an Understudied Population From the Eastern Mediterranean.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  29. MARDEN JR, Mayeda ER, Walter S, Vivot A, et al
    Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  30. HORVATH A, Szucs A, Barcs G, Noebels JL, et al
    Epileptic Seizures in Alzheimer Disease: A Review.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  31. GERSTENECKER A, Triebel KL, Martin R, Snyder S, et al
    Both Financial and Cognitive Decline Predict Clinical Progression in MCI.
    Alzheimer Dis Assoc Disord. 2016;30:27-34.
    PubMed     Text format     Abstract available


  32. WALTER S, Marden JR, Kubzansky LD, Mayeda ER, et al
    Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.
    Alzheimer Dis Assoc Disord. 2016;30:15-20.
    PubMed     Text format     Abstract available


    December 2015
  33. DICK MB, Doran E, Phelan M, Lott IT, et al
    Cognitive Profiles on the Severe Impairment Battery are Similar in Alzheimer Disease and Down Syndrome With Dementia.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  34. REGNER I, Mazerolle M, Alescio-Lautier B, Clarys D, et al
    Aging Stereotypes Must be Taken Into Account for the Diagnosis of Prodromal and Early Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  35. KNAPSKOG AB, Engedal K, Braekhus A
    Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


    November 2015
  36. SCIALO C, Ferrara M, Accardo J, Morbelli S, et al
    Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis?
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


    October 2015
  37. ASHISH N, Bhatt P, Toga AW
    Global Data Sharing in Alzheimer Disease Research.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  38. COLEMAN KK, Coleman BL, MacKinley JD, Pasternak SH, et al
    Detection and Differentiation of Frontotemporal Dementia and Related Disorders From Alzheimer Disease Using the Montreal Cognitive Assessment.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  39. OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PH, et al
    Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  40. CALLAHAN CM, Hendrie HC
    Errors in Self-Reports of Health Services Use: Impact on Alzheimer Disease Clinical Trial Designs.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


  41. DECARLI C
    Editorial Transition at Alzheimer's Disease and Associated Disorders.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


  42. GODEFROY O, Martinaud O, Verny M, Mosca C, et al
    Cross-Validation of a Shortened Battery for the Assessment of Dysexecutive Disorders in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  43. GRILL JD, Karlawish J
    Consider the Source: The Implications of Informant Type on Outcome Assessments.
    Alzheimer Dis Assoc Disord. 2015;29:364.
    PubMed     Text format    


    September 2015
  44. PERRY CE, Gale SD, Erickson L, Wilson E, et al
    Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  45. PELTON GH, Soleimani L, Roose SP, Tabert MH, et al
    Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


    August 2015
  46. TRAVIS SEIDL JN, Massman PJ
    Cognitive and Functional Correlates of NPI-Q Scores and Symptom Clusters in Mildly Demented Alzheimer Patients.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


    July 2015
  47. CAHILL S, Pierce M, Werner P, Darley A, et al
    A Systematic Review of the Public's Knowledge and Understanding of Alzheimer's Disease and Dementia.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  48. BERNARD BL, Bracey LE, Lane KA, Ferguson DY, et al
    Correlation Between Caregiver Reports of Physical Function and Performance-based Measures in a Cohort of Older Adults With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  49. LUCHSINGER JA
    Editorial Transition at Alzheimer's Disease and Associated Disorders.
    Alzheimer Dis Assoc Disord. 2015;29:183.
    PubMed     Text format    


    May 2015
  50. GRILL JD, Vinters HV, Monsell SE
    Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints?
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


  51. LENZ RA, Pritchett YL, Berry SM, Llano DA, et al
    Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  52. CASELLI RJ, Marchant GE, Hunt KS, Henslin BR, et al
    Predictive Testing for Alzheimer's Disease: Suicidal Ideation in Healthy Participants.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


    April 2015
  53. MCMULLEN DP, Rosenberg P, Cheng J, Smith GS, et al
    Bilateral Cortical Encephalomalacia in a Patient Implanted With Bilateral Deep Brain Stimulation for Alzheimer's Disease: Case Report.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format    


  54. GANGULI M
    Cancer and Dementia: It's Complicated.
    Alzheimer Dis Assoc Disord. 2015;29:177-82.
    PubMed     Text format     Abstract available


  55. CHANG HT, Chiu MJ, Chen TF, Cheng TW, et al
    Distinct Patterns and Clinical Implications of Semantic Memory Deterioration Among Patients With MCI.
    Alzheimer Dis Assoc Disord. 2015;29:124-34.
    PubMed     Text format     Abstract available


  56. MOELTER ST, Glenn MA, Xie SX, Chittams J, et al
    The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores.
    Alzheimer Dis Assoc Disord. 2015;29:158-60.
    PubMed     Text format    


  57. MOSCHETTI K, Barragan N, Basurto-Davila R, Cummings PL, et al
    Mortality and Productivity Losses From Alzheimer Disease Among US Adults Aged 40 to 64 Years, 1999 to 2010.
    Alzheimer Dis Assoc Disord. 2015;29:165-8.
    PubMed     Text format    


  58. BUFILL E, Roura-Poch P, Sala-Matavera I, Anton S, et al
    Reelin signaling pathway genotypes and Alzheimer disease in a Spanish population.
    Alzheimer Dis Assoc Disord. 2015;29:169-72.
    PubMed     Text format     Abstract available


  59. PERRY DC, Sturm VE, Wood KA, Miller BL, et al
    Divergent processing of monetary and social reward in behavioral variant frontotemporal dementia and Alzheimer disease.
    Alzheimer Dis Assoc Disord. 2015;29:161-4.
    PubMed     Text format    


    March 2015
  60. DROOGSMA E, van Asselt D, van Steijn J, Diekhuis M, et al
    Long-term Course of Alzheimer Disease in Patients Treated According to the Dutch Dementia Guideline at a Memory Clinic: A "Real-Life" Study.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


    February 2015
  61. ECONOMOU A, Routsis C, Papageorgiou SG
    Episodic Memory in Alzheimer Disease, Frontotemporal Dementia, and Dementia With Lewy Bodies/Parkinson Disease Dementia: Disentangling Retrieval From Consolidation.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  62. WU Z, Yang B, Liu C, Liang G, et al
    Long-term Dantrolene Treatment Reduced Intraneuronal Amyloid in Aged Alzheimer Triple Transgenic Mice.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


    January 2015
  63. GILDEN DM, Kubisiak JM, Sarsour K, Hunter CA, et al
    Diagnostic Pathways to Alzheimer Disease: Costs Incurred in a Medicare Population.
    Alzheimer Dis Assoc Disord. 2015.
    PubMed     Text format     Abstract available


  64. CARY MS, Rubright JD, Grill JD, Karlawish J, et al
    Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?
    Alzheimer Dis Assoc Disord. 2015;29:70-4.
    PubMed     Text format     Abstract available


  65. MENDEZ MF, Sabodash V
    Clinical amyloid imaging in logopenic progressive aphasia.
    Alzheimer Dis Assoc Disord. 2015;29:94-6.
    PubMed     Text format     Abstract available


    December 2014
  66. GRILL JD, Zhou Y, Karlawish J, Elashoff D, et al
    Frequency and Impact of Informant Replacement in Alzheimer Disease Research.
    Alzheimer Dis Assoc Disord. 2014.
    PubMed     Text format     Abstract available


  67. LIANG L, Wei H
    Dantrolene, A Treatment for Alzheimer Disease?
    Alzheimer Dis Assoc Disord. 2014.
    PubMed     Text format     Abstract available


    November 2014
  68. CAROLI A, Prestia A, Wade S, Chen K, et al
    Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
    Alzheimer Dis Assoc Disord. 2014.
    PubMed     Text format     Abstract available


  69. FARLOW MR, Grossberg GT, Sadowsky CH, Meng X, et al
    A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2014.
    PubMed     Text format     Abstract available


    July 2014
  70. DUFF K, Foster NL, Hoffman JM
    Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.
    Alzheimer Dis Assoc Disord. 2014;28:247-52.
    PubMed     Text format     Abstract available


  71. KAUR B, Himali JJ, Seshadri S, Beiser AS, et al
    Association between neuropathology and brain volume in the Framingham Heart Study.
    Alzheimer Dis Assoc Disord. 2014;28:219-25.
    PubMed     Text format     Abstract available


    April 2014
  72. MCCULLOCH K, Collins RL, Maestas KL, LeMaire AW, et al
    Validation and diagnostic utility of the dementia rating scale in a mixed dementia population.
    Alzheimer Dis Assoc Disord. 2014;28:168-74.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: